Jefferies Group’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.47M | Buy |
21,049
+11,233
| +114% | +$785K | 0.01% | 402 |
|
|
2022
Q2 | $659K | Sell |
9,816
-65,530
| -87% | -$4.4M | 0.01% | 530 |
|
|
2022
Q1 | $6.19M | Buy |
75,346
+27,965
| +59% | +$2.3M | 0.04% | 166 |
|
|
2021
Q4 | $6.95M | Buy |
+47,381
| New | +$6.95M | 0.04% | 155 |
|
|
2021
Q3 | – | Sell |
-2,854
| Closed | -$461K | – | 1367 |
|
|
2021
Q2 | $461K | Sell |
2,854
-7,279
| -72% | -$1.18M | ﹤0.01% | 739 |
|
|
2021
Q1 | $1.74M | Sell |
10,133
-87,447
| -90% | -$15M | 0.02% | 424 |
|
|
2020
Q4 | $21.4M | Buy |
97,580
+13,725
| +16% | +$3.01M | 0.17% | 39 |
|
|
2020
Q3 | $13.9M | Sell |
83,855
-3,058
| -4% | -$508K | 0.15% | 39 |
|
|
2020
Q2 | $9.92K | Sell |
86,913
-640
| -0.7% | -$73 | 0.12% | 63 |
|
|
2020
Q1 | $6.73M | Buy |
87,553
+22,932
| +35% | +$1.76M | 0.07% | 104 |
|
|
2019
Q4 | $8.33M | Sell |
64,621
-4,772
| -7% | -$615K | 0.06% | 119 |
|
|
2019
Q3 | $5.41M | Buy |
69,393
+69,193
| +34,597% | +$5.39M | 0.04% | 195 |
|
|
2019
Q2 | $21K | Buy |
+200
| New | +$21K | ﹤0.01% | 1495 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 1770 |
|
|
2018
Q4 | – | Sell |
-1,800
| Closed | -$85K | – | 1797 |
|
|
2018
Q3 | $85K | Buy |
+1,800
| New | +$85K | ﹤0.01% | 1493 |
|